Mutual of America Capital Management LLC lessened its stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 3.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,593 shares of the technology company’s stock after selling 1,741 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Novanta were worth $6,947,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Teacher Retirement System of Texas increased its holdings in Novanta by 5.3% in the 4th quarter. Teacher Retirement System of Texas now owns 2,914 shares of the technology company’s stock valued at $491,000 after purchasing an additional 146 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Novanta by 7.7% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,353 shares of the technology company’s stock worth $367,000 after purchasing an additional 169 shares during the period. Norges Bank acquired a new stake in shares of Novanta during the fourth quarter worth about $62,186,000. PNC Financial Services Group Inc. lifted its position in shares of Novanta by 6.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,291 shares of the technology company’s stock worth $554,000 after purchasing an additional 204 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of Novanta by 299.9% in the fourth quarter. Wells Fargo & Company MN now owns 61,912 shares of the technology company’s stock valued at $10,427,000 after purchasing an additional 46,430 shares during the period. 98.35% of the stock is currently owned by institutional investors and hedge funds.
Novanta Stock Up 3.3 %
NOVT stock opened at $174.37 on Friday. The company’s 50 day moving average price is $175.76 and its 200 day moving average price is $168.49. The firm has a market capitalization of $6.26 billion, a price-to-earnings ratio of 90.35 and a beta of 1.29. Novanta Inc. has a fifty-two week low of $111.20 and a fifty-two week high of $187.12. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.73 and a current ratio of 2.77.
Insider Buying and Selling at Novanta
In other Novanta news, CFO Robert Buckley sold 1,830 shares of Novanta stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $161.09, for a total transaction of $294,794.70. Following the completion of the sale, the chief financial officer now directly owns 120,419 shares of the company’s stock, valued at approximately $19,398,296.71. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Novanta news, CEO Matthijs Glastra sold 1,086 shares of the firm’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $160.84, for a total transaction of $174,672.24. Following the sale, the chief executive officer now owns 23,486 shares of the company’s stock, valued at $3,777,488.24. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Robert Buckley sold 1,830 shares of the company’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $161.09, for a total transaction of $294,794.70. Following the completion of the transaction, the chief financial officer now owns 120,419 shares of the company’s stock, valued at approximately $19,398,296.71. The disclosure for this sale can be found here. Insiders have sold a total of 15,063 shares of company stock worth $2,591,881 over the last ninety days. Corporate insiders own 1.20% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Robert W. Baird raised their price target on shares of Novanta from $170.00 to $175.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th.
Read Our Latest Analysis on NOVT
Novanta Profile
Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
Further Reading
- Five stocks we like better than Novanta
- What Are Dividend Achievers? An Introduction
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 3 Warren Buffett Stocks to Buy Now
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Stock Sentiment Analysis: How it Works
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.